Ordinary Adjustment | Solactive Longevity Index | Effective Date 3rd March 2025
Solactive Longevity Index:
In the ordinary adjustment, the following composition will be implemented effective open 3rd March 2025:
| ABBOTT LABORATORIES |
| ALIBABA HEALTH INFORMATION TECHNOLOGY LTD |
| APOGEE THERAPEUTICS ORD |
| CRISPR THERAPEUTICS AG |
| DEXCOM INC |
| EDITAS MEDICINE INC |
| EISAI |
| ELI LILLY & CO |
| GE HEALTHCARE TECHNOLOGIES INC |
| HIMS & HERS HEALTH INC |
| INTELLIA THERAPEUTICS INC |
| INTUITIVE SURGICAL INC |
| IRHYTHM TECHNOLOGIES INC |
| JOHNSON & JOHNSON |
| KONINKLIJKE PHILIPS NV |
| LANTHEUS HOLDINGS INC |
| LIFEMD INC |
| MEDTRONIC PLC |
| NANO-X IMAGING LTD |
| NOVO NORDISK A/S |
| PRIME MEDICINE INC |
| PROCEPT BIOROBOTICS ORD |
| RADNET INC |
| SANGAMO THERAPEUTICS INC |
| SHANGHAI MICROPORT MEDBOT GR |
| STRYKER CORP |
| TELADOC HEALTH INC |
| UFP TECHNOLOGIES INC |
| VAREX IMAGING CORP |
| WELL HEALTH TECHNOLOGIES CORP |